Lifecore Biomedical Sees FY2026 Sales $120.000M-$125.000M vs $129.846M Est
Benzinga Newsdesk 7 months ago
NewsGuidance
Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $120.000 million-$125.000 million vs $129.846 million analyst estimate.
Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $120.000 million-$125.000 million vs $129.846 million analyst estimate.